![]() |
市场调查报告书
商品编码
1551257
到 2030 年血管塞的市场预测:按产品、材料、分销管道、应用、最终用户和地区进行全球分析Vascular Plugs Market Forecasts to 2030 - Global Analysis By Product (Absorbable Vascular Plugs and Non-Absorbable Vascular Plugs), Material, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球血管塞市场规模为 1.2564 亿美元,预计在预测期内将以 8.7% 的复合年增长率增长,到 2030 年达到 2.1052 亿美元。
血管塞是医疗设备,常用于外科手术和治疗血管异常。这些塞子旨在阻断或阻断特定血管中的血流,通常用于防止出血或促进血管网路基地台的闭合。它们通常由生物相容性材料製成,例如聚合物或金属,并具有各种尺寸和形状以适应不同的血管。
根据《柳叶刀》杂誌发表的一篇论文,2019 年 8 月,全球 25 岁以上族群的周边动脉疾病(PAD) 盛行率估计约为 5.5%。
血管疾病盛行率增加
随着动脉瘤、动静脉畸形和周边动脉疾病等疾病变得越来越常见,对血管塞来管理和治疗这些问题的需求也随之增加。寻求介入的患者数量不断增加,促使医疗保健提供者采用先进的血管栓塞技术。这种不断增长的需求正在推动创新和市场扩张,医疗设备製造商正在开发新的和改进的血管塞,以服务日益多样化的患者群体,从而促进市场成长。
併发症的风险
血管栓塞併发症的风险,例如栓塞迁移、感染和血栓性栓塞症,是由装置材质、放置精确度和患者俱体情况等因素造成的。这些併发症可能导致不良后果,需要额外的介入和治疗。这些风险可能会降低血管塞的整体接受度和采用率,从而阻碍市场成长。医疗保健提供者可能对推荐这些设备持谨慎态度,并且对安全性和有效性的更多关注可能会导致更高的成本和监管障碍,这可能会阻碍市场扩张。
微创手术的增加
血管内手术等微创手术需要精确可靠的工具来控制血流并确保成功的结果。血管塞旨在密封血管并防止渗漏,对于这些手术至关重要。随着微创手术方法的趋势持续发展,对先进血管塞的需求不断增加,推动了市场成长。这种转变缩短了患者的康復时间并减少了併发症,进一步刺激了对这些设备的需求。
先进仪器高成本
先进血管塞的成本高是由于技术先进、材料优质、研发投入大等因素。这些成本可能会限制其使用,特别是在发展中地区和小型医疗机构。高价格也可能给医疗保健预算带来压力,导致先进血管塞的采用被推迟或使用受到限制。这些经济障碍减少了整体需求,限制了产品的可用性,并限制了尖端血管栓塞技术在各种医疗保健环境中的广泛采用,从而阻碍了市场的成长。
COVID-19 的影响
COVID-19 大流行导致选择性和非紧急手术的延误并减少了整体需求,从而扰乱了血管栓塞市场。供应链中断和医疗资源的重新分配进一步影响了市场。然而,在大流行期间,对远端医疗和微创手术的日益关注推动了创新血管栓塞技术的发展。一旦医疗保健系统恢復并恢復选择性治疗,由于新的需求和医疗技术的进步,市场预计将復苏。
聚合物细分市场预计将在预测期内成为最大的细分市场
聚合物产业预计将出现良好的成长。聚合物材料具有生物相容性、柔韧性和强度等优点,在血管栓塞的开发中扮演重要角色。常用的聚合物包括聚乙烯、聚氨酯和聚乳酸,它们有助于有效闭塞血管,同时最大限度地降低发炎和血栓症的风险。这些材料可以被设计为具有受控的降解速率,并且可以逐渐融入体内。聚合物技术的进步不断提高血管塞在各种医疗应用中的性能和安全性。
预计心血管手术在预测期内复合年增长率最高
心血管外科领域预计在预测期内将出现最高的复合年增长率。血管栓塞在心血管手术中非常重要,可以控制血管通路部位并防止出血和渗漏等併发症。这些装置用于暂时或永久闭塞血管,确保止血并最大限度地减少手术期间和手术后不利事件的风险。血管栓塞在需要精确控制血流的手术中尤其重要,例如血管内修復和基于导管的干预措施。其设计和功能有助于改善患者预后并缩短復原时间。
由于血管疾病的增加、老年人口的增加以及医疗技术的进步,亚太地区的血管栓塞市场正在显着成长。医疗保健基础设施投资的增加和微创手术的快速增加正在推动对血管塞的需求。中国、印度和日本等国家因其庞大的患者群体和设备齐全的医疗设施而引领成长。此外,先进医疗设备的认知度和可近性的提高也有助于该地区的市场扩张。
由于血管疾病的高发病率和发达的医疗基础设施,北美的血管栓塞市场强劲。该地区受益于先进医疗技术和研发的大量投资。微创手术的日益普及和大量患者群体也促进了市场的成长。此外,领先医疗设备製造商的存在和优惠的报销政策进一步推动了血管栓塞市场的扩张。
According to Stratistics MRC, the Global Vascular Plugs Market is accounted for $125.64 million in 2024 and is expected to reach $210.52 million by 2030 growing at a CAGR of 8.7% during the forecast period. Vascular plugs are medical devices used to occlude blood vessels, typically during surgical procedures or in the treatment of vascular abnormalities. These plugs are designed to block or seal off blood flow in a specific vessel, often to prevent bleeding or to facilitate the closure of vascular access points. They are commonly made from biocompatible materials such as polymers or metals and come in various sizes and shapes to fit different vessels.
According to an article published in The Lancet, in August 2019, the global prevalence of peripheral artery disease (PAD) in people aged 25 years and above was estimated to be around 5.5%.
Rising incidence of vascular diseases
As conditions such as aneurysms, arteriovenous malformations, and peripheral artery disease become more prevalent, there is a greater need for vascular plugs to manage and treat these issues. The increased number of patients seeking interventions drives healthcare providers to adopt advanced vascular plug technologies. This heightened demand stimulates innovation and market expansion, as medical device manufacturers develop new and improved vascular plugs to address a growing and diverse patient population, thereby contributing to market growth.
Risk of complications
The risk of complications in vascular plugs, such as plug migration, infection, or thromboembolism, arises from factors like device material, placement accuracy, and patient-specific conditions. These complications can lead to adverse outcomes, requiring additional interventions or treatments. Such risks can hamper market growth by reducing the overall acceptance and adoption of vascular plugs. Healthcare providers may be cautious in recommending these devices, and increased focus on safety and effectiveness can lead to higher costs and regulatory hurdles, slowing market expansion.
Growing number of minimally invasive procedures
Minimally invasive techniques, such as endovascular surgeries, require precise and reliable tools to control blood flow and ensure successful outcomes. Vascular plugs, designed for sealing vessels and preventing leaks, are essential in these procedures. As the trend towards less invasive surgical options continues, the need for advanced vascular plugs rises, propelling market growth. This shift improves patient recovery times and reduces complications, further fueling demand for these devices.
High cost of advanced devices
The high cost of advanced vascular plug devices is driven by factors such as sophisticated technology, high-quality materials, and extensive R&D investments. These costs can limit their accessibility, particularly in developing regions or for smaller healthcare facilities. The high prices can also strain healthcare budgets and lead to delayed adoption or restricted use of advanced vascular plugs. This financial barrier hampers market growth by reducing overall demand, limiting product availability, and restricting the broader implementation of cutting-edge vascular plug technologies in various healthcare settings.
Covid-19 Impact
The covid-19 pandemic disrupted the vascular plugs market by causing delays in elective and non-emergency procedures, reducing overall demand. Supply chain interruptions and healthcare resource reallocation further impacted the market. However, the increased focus on telemedicine and minimally invasive procedures during the pandemic created a push for innovative vascular plug technologies. As healthcare systems recover and elective procedures resume, the market is expected to rebound, driven by renewed demand and advancements in medical technology.
The polymers segment is expected to be the largest during the forecast period
The polymers segment is estimated to have a lucrative growth. Polymer materials play a crucial role in the development of vascular plugs, offering benefits such as biocompatibility, flexibility, and strength. Commonly used polymers include polyethylene, polyurethane, and polylactic acid, which help ensure the plugs effectively occlude blood vessels while minimizing inflammation and thrombosis risks. These materials can be engineered to provide controlled degradation rates, allowing for gradual integration into the body. Advances in polymer technology continue to enhance the performance and safety of vascular plugs in various medical applications.
The cardiovascular surgery segment is expected to have the highest CAGR during the forecast period
The cardiovascular surgery segment is anticipated to witness the highest CAGR growth during the forecast period. Vascular plugs are critical in cardiovascular surgery for managing vascular access sites and preventing complications such as bleeding or leakage. These devices are used to occlude blood vessels temporarily or permanently, ensuring hemostasis and minimizing the risk of adverse events during and after procedures. Vascular plugs are particularly important in procedures like endovascular repair and catheter-based interventions, where precise control over blood flow is essential. Their design and functionality contribute to improved patient outcomes and reduced recovery times.
The vascular plugs market in the Asia-Pacific region is experiencing significant growth due to rising incidences of vascular diseases, an expanding elderly population, and advancements in medical technologies. Increasing healthcare infrastructure investments and a surge in minimally invasive procedures are driving demand for vascular plugs. Countries like China, India, and Japan are leading the growth due to their large patient populations and improving healthcare facilities. Additionally, growing awareness and accessibility to advanced medical devices are contributing to the market's expansion in this region.
In North America, the vascular plugs market is robust due to high prevalence rates of vascular diseases and a well-established healthcare infrastructure. The region benefits from advanced medical technologies and significant investment in research and development. Increasing adoption of minimally invasive procedures and a large patient population contribute to market growth. Additionally, the presence of major medical device manufacturers and favourable reimbursement policies further support the expansion of the vascular plugs market.
Key players in the market
Some of the key players profiled in the Vascular Plugs Market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Terumo Corporation, Johnson & Johnson, Cook Medical Inc., Gore & Associates, Asahi Intecc Co., Ltd., Merit Medical Systems, Inc., Cardinal Health, Inc., AngioDynamics, Inc., Philips Healthcare, Becton, Dickinson and Company, AtriCure, Inc., Neovasc Inc., Endologix, Inc., Stryker Corporation, MicroVention, Inc. and Royal Philips.
In May 2024, Merit Medical Systems, Inc. announced FDA 510(k) clearance for its Siege vascular plug. The nitinol, self-expanding Siege vascular plug is designed to be highly deliverable and recapturable to enable precise placement while achieving vessel occlusion within 1.3 minutes. Siege is available in three sizes to treat peripheral arteries from 1.5 to 6.0 mm in diameter. All sizes are delivered with a microcatheter.
In July 2021, Terumo Medical Corporation (TMC) has unveiled its AZUR(TM) Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization portfolio is indicated for use to reduce or block the rate of blood flow in arteries of the peripheral vasculature.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.